Cumberland Pharmaceuticals (CPIX) Retained Earnings (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Retained Earnings data on file, last reported at -$30.1 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 32.51% year-over-year to -$30.1 million; the trailing twelve-month figure through Mar 2026 stood at -$30.1 million (down 32.51% YoY), and the FY2025 full-year result was -$26.8 million, down 11.83% from the prior year.
• Retained Earnings fell to -$30.1 million in Q1 2026, from -$26.8 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$7.0 million in Q1 2022 to a low of -$30.1 million in Q1 2026.
• A 5-year average of -$17.6 million and a median of -$19.4 million in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings tumbled 1036.38% in 2022 and dropped 11.83% in 2025, its largest moves.
• Tracing CPIX's Retained Earnings over 5 years: stood at -$11.2 million in 2022, then plunged by 56.02% to -$17.5 million in 2023, then plunged by 37.05% to -$24.0 million in 2024, then declined by 11.83% to -$26.8 million in 2025, then decreased by 12.27% to -$30.1 million in 2026.
• Business Quant data shows CPIX's Retained Earnings at -$30.1 million in Q1 2026, -$26.8 million in Q4 2025, and -$25.4 million in Q3 2025.